Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 144

Similar articles for PubMed (Select 10083337)

1.

Donor antigen-independent effector mechanisms of graft rejection: a novel cell surface target of IL-2-activated natural killer cells.

Norin AJ, Brewer RJ, Lui Q, Del Rio MJ, Burack J, Kamholz SL.

Transplant Proc. 1999 Feb-Mar;31(1-2):787-8. No abstract available.

PMID:
10083337
2.

IL-2 activated killer cell activity is associated with the early phase of allograft rejection.

Kamholz S, Roslin M, Mondragon M, Coons M, Tranbaugh R, Strashun A, Manjoney D, Norin A.

Transplant Proc. 1991 Feb;23(1 Pt 1):597-8. No abstract available.

PMID:
1990620
3.

Donor-specific cytotoxic lymphocyte activity from bronchoalveolar lavage during acute canine lung allograft rejection.

Sekine Y, Fujisawa T, Saitoh Y, Takeda T, Yoshida S, Urabe N, Baba M, Yamaguchi Y.

Eur J Cardiothorac Surg. 1997 May;11(5):902-9.

PMID:
9196307
5.
6.
7.

Development of immunological assays to monitor pulmonary allograft rejection.

Cunningham AC, Kirby JA, Colquhoun IW, Flecknell PA, Ashcroft T, Dark JH.

Thorax. 1994 Feb;49(2):151-6.

8.

Usefulness of bronchoalveolar cell profile in early detection of canine lung allograft rejection.

Chang SC, Hsu HK, Lin CY.

Immunol Lett. 1991 Aug;29(3):265-70.

PMID:
1769709
9.

Early cellular events in the lung allograft.

Adoumie R, Serrick C, Giaid A, Shennib H.

Ann Thorac Surg. 1992 Dec;54(6):1071-6; discussion 1076-7.

PMID:
1449289
10.

Lung transplantation in the rat: a model for study of the cellular mechanisms of allograft rejection.

Kirby JA, Parfett GJ, Reader JA, Pepper JR.

Immunology. 1988 Mar;63(3):369-72.

11.

Donor-specific cytotoxicity testing: an advance in detecting pulmonary allograft rejection.

Dal Col RH, Zeevi A, Rabinowich H, Herlan DB, Yousem SA, Griffith BP.

Ann Thorac Surg. 1990 May;49(5):754-8.

PMID:
2339932
12.
13.

Lung transplantation in the rat: cellular mechanisms of allograft rejection.

Pepper JR, Parfett GJ, Reader JA, Kirby JA.

Transplant Proc. 1989 Feb;21(1 Pt 1):470-2. No abstract available.

PMID:
2650180
14.

Prolonged pulmonary xenograft survival: tissue infiltration compared with infiltration in the bronchoalveolar space.

Fraund S, Tschernig T, You XM, Mörike C, Emmendörffer A, Rittinghausen S, Pabst R, Haverich A, Steinhoff G.

Transplant Proc. 1999 Feb-Mar;31(1-2):932-3. No abstract available.

PMID:
10083412
15.

NK cells contribute to the skin graft rejection promoted by CD4+ T cells activated through the indirect allorecognition pathway.

Ito A, Shimura H, Nitahara A, Tomiyama K, Ito M, Kanekura T, Okumura K, Yagita H, Kawai K.

Int Immunol. 2008 Oct;20(10):1343-9. doi: 10.1093/intimm/dxn092. Epub 2008 Aug 12.

16.

Expression of gamma-IFN mRNA in bronchoalveolar lavage fluid correlates with early acute allograft rejection in lung transplant recipients.

Moudgil A, Bagga A, Toyoda M, Nicolaidou E, Jordan SC, Ross D.

Clin Transplant. 1999 Apr;13(2):201-7.

PMID:
10202618
17.

Evaluation with enzyme-linked immunosorbent assay spot detection of the frequency of interferon-gamma-producing T cells in bronchoalveolar lavage is useful in identifying lung transplant patients at higher risk of acute rejection.

Meloni F, Paschetto E, Cascina A, Marone Bianco A, Pellegrini C, Oggionni T, Vitulo P, Viganò M.

Transplant Proc. 2001 Nov-Dec;33(7-8):3286-8. No abstract available.

PMID:
11750407
18.

Renal allograft rejection: possible involvement of lymphokine-activated killer cells.

Kirby JA, Forsythe JL, Proud G, Taylor RM.

Immunology. 1989 May;67(1):62-7.

19.

Distribution of TCR alpha beta+ and TCR gamma delta+ lymphocytes in bronchoalveolar lavage from human lung transplant recipients.

Whitehead BF, Stoehr C, Finkle C, Patterson G, Theodore J, Clayberger C, Starnes VA.

Transplantation. 1993 Oct;56(4):1031-4. No abstract available.

PMID:
8212186
20.

Natural killer cells in haematopoietic stem cell transplantation.

Lowdell MW.

Transfus Med. 2003 Dec;13(6):399-404. Review.

PMID:
14651745
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk